2013

Another compounder has announced the recall of all products, joining an ever-lengthening list of companies that have had to make similar announcements.  Thankfully, it reportedly didn’t take a slew of adverse incident reports to be issued before this particular recall was issued. The defective product recall was announced by Green Valley Drugs, a compounding pharmacy… read more

Another compounder is recalling a host of products because their sterility cannot be guaranteed.  This latest recall joins a number of similar recalls issued in recent weeks. Previously, a New Jersey-based compounder known as MedPrep recalled all of their compounded products after a hospital in Connecticut identified particulates in a series of items.  Those contamination… read more

This week has not been kind to compounding pharmacies, nor has the past year.  A 2012 mold contamination hazard tied to products from a Massachusetts facility led to a widespread outbreak across the country, leading regulators to reconsider the way that such operations are regulated.  And this week, a New Jersey compounder had to recall… read more

Compounding pharmacies are in the news once again.  Months ago, the presence of mold in products from a Massachusetts-based facility led to fatalities across the country, and the incident prompted lawmakers to take another look at how the operations of compounders are overseen by local and federal officials.  The Food and Drug Administration vowed to… read more

The Food and Drug Administration is warning consumers and healthcare professionals of the dangers posed by a drug meant to treat anemia in those adult persons going through dialysis.  If you fall into this category, then it’s imperative that you read on to learn more about the hazard posed by the drug. The recall being… read more

Vistide (cidofovir injection) from lot number B120217A is being recalled by Gilead Sciences.  Certain vials were shown to contain particulates, and thus those versions of the injection with an expiration date of May 2015 are being recalled.  No one has reported sustaining any type of adversity in conjunction with this item, but the company takes… read more

Reumofan Plus sold across the country is being recalled because the labels fail to declare those drugs that are present within the medication.  The recall pertains to products from Lot 99515 that have an expiration date of 09/16.  One person has already reported sustaining an illness in association with this product, which was available in… read more

A fungal meningitis outbreak that caused numerous illnesses and fatalities across the country in the past few months has led lawmakers to reconsider the way that compounding pharmacies are regulated.  In particular, the Commissioner of the Food and Drug Administration has asked Congress to more clearly delineate who has authority over compounders.  She said that… read more

A series of items that are designed to treat advanced ovarian carcinoma are being recalled because of the potential for visible particulate matter within the injections.  Hospira announced the recall, which affects three lots of Carboplatin Injections in a 45 or 60 milliliter Multi Dose Vial.  Lots Z011711AA, Z011711AB, and Z021650AA are being recalled, and… read more

Compounding pharmacies have been in the news as of late following a fungal meningitis outbreak that stemmed from contaminated steroids distributed by the New England Compounding Center.  The House of Representatives, in a bid to ensure safety from these types of outbreaks in the future, is looking into the possible passage of a bill known… read more

What happens when a recall gets issued but there are differing opinions on how dangerous usage of the item can be to consumers?  That’s the issue now that word of a recall of a generic version of Lipitor known as atovastatin has reached the public. The Food and Drug Administration informed the country of that… read more

Compounding pharmacies have become a target of scrutiny now that the New England Compounding Center has been found to have distributed contaminated injectable steroids across the country, leading to a widespread outbreak of fungal meningitis that has claimed numerous lives.  With Congress and the FDA looking into what can be done to promote safety in… read more